Respiratory Virus Sampling and Repository Study
This study is collecting samples from people with respiratory viruses like the flu (Influenza) and COVID-19. Researchers want to learn more about these infections and how the body's immune system responds to them. The goal is to build a collection of these samples over 10 years for future research, which could help in developing new tests, treatments, and vaccines. You can join if you are 3 years or older and have, or are suspected of having, a respiratory virus infection. The study aims to collect samples from up to 20,000 participants.
- Study design
- This is an observational study, meaning researchers will collect information and samples without giving any specific treatments. It plans to enroll up to 20,000 participants.
- What's involved
- You would have a medical record review, provide blood samples, and give nose samples using a soft plastic strip in each nostril for about a minute. Data from your medical records will also be collected.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary goal is to isolate virus specimens over a 10-year period, but it's not specified how long individual participants are followed after their initial samples are collected.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Respiratory Virus Sampling and Repository
At a glance
Conditions
Where it's being run
2 sites across 1 statesStudy leadership
- Matthew J Memoli, M.D. · PRINCIPAL_INVESTIGATOR · National Institute of Allergy and Infectious Diseases (NIAID)
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- To isolate human respiratory virus specimens10 years
To isolate human respiratory virus specimens and maintain them in a repository for future use in laboratory assays, animal experiments, development of challenge viruses, and development of vaccines, described in a separate protocol.